Advertisement
Screener

Co-Diagnostics, Inc. (CODX) Accounts Receivable, Allowance for Credit Loss, Recovery

2.8 / 5 stars · 68/120 Roast Me

Co-Diagnostics, Inc. Accounts Receivable, Allowance for Credit Loss, Recovery

Co-Diagnostics, Inc. (CODX) reported Accounts Receivable, Allowance for Credit Loss, Recovery of $26.01 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.

Financial Statements › Notes › and Others

us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries · last filed 2026-03-31

  • Co-Diagnostics, Inc. accounts receivable, allowance for credit loss, recovery for fiscal 2025 was $26.01K, a 72.97% increase from fiscal 2024.
  • Co-Diagnostics, Inc. accounts receivable, allowance for credit loss, recovery for fiscal 2024 was $15.04K.
Period endAccounts Receivable, Allowance for Credit Loss, Recovery 12 month
2025-12-31$26.01K
10-K · filed 2026-03-31
2024-12-31$15.04K
10-K · filed 2026-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
AETHLON MEDICAL INC (AEMD)United States$0.005B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
ALLURION TECHNOLOGIES, INC. (ALUR)United States$0.010B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Picard Medical, Inc. (PMI)United States$0.011B-0.01